Adiponectin has insulin-sensitizing anti-inflammation and anti-atherogenic properties, and it hence exerts a protective role in type 2 diabetes mellitus, obesity, hypertension and coronary artery disease [27, 28]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.